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Introduction: Locomotion is a determinant of intrinsic capacity of 
older people and can be limited by dysfunction in locomotory organs, 
characterizing Locomotive Syndrome (LoS). Knowledge on locomotive 
problems and sarcopenia, and their interface with quality of life, in the 
oldest old in the literature is scarce.
Objective: To evaluate the correlation between LoS and sarcopenia and 
their influence on quality of life in oldest old.
Methods: A cross-sectional study of an observational, descriptive and 
analytical epidemiological survey in independent older adults aged 80 
and over from São Paulo, Brazil and who participated in the third wave 
of the LOCOMOV Project, was carried out. Sociodemographic data, 
comorbidities, functioning in activities of daily living, physical functioning, 
quality of life, and presence of sarcopenia and LoS were assessed. The 
statistical analyses included the Test-for-Comparing-Two-Proportions, 
Pearson's Correlation Coefficient, the chi-Square test and Student´s t-test.
Results: Thirty oldest old with a mean age of 89.1 years were evaluated. 
The prevalence of LoS was high (53.3%) and correlated significantly with 
chronic pain (p-value 0.024), worse performance on the SPPB and Gait 
speed (p-value <0.001). Sarcopenia was not correlated with LoS, but worse 
quality of life on the physical domain was significantly associated with LoS 
(p-value <0.001) regardless of the presence of sarcopenia.
Conclusions: LoS was highly prevalent among the oldest old studied and 
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1. Introduction
According to the 2015 Aging and Health Report by the 
World Health Organization (WHO), for the first time in 
history, the majority of the population can expect to live 
to 60 years or older [1]. However, these extra years of life 
are highly heterogeneous due to factors such as genetics 
and the physical and social environments to which the 
older person is exposed. Functional capacity represents a 
combination of an individual´s intrinsic capacity and their 
relationship and interaction with the environment [1].
In 2019, Beard et al. outlined five determinants that 
define an individual's intrinsic capacity: cognition, 
locomotion, sensory and psychological determinants and 
vitality. Since then, an assessment model that correlates 
these factors has been proposed as an alternative to the 
fragmented view of independent factors. Mobility is 
associated with vitality and both are, therefore, closely 
related to healthy aging and quality of life in older people [2]. 
Thus, identifying the factors that influence locomotory 
independence in older individuals is an essential element 
of health care and promotion. The concept of Locomotive 
Syndrome (LoS) was first proposed in 2007 by the 
Japanese, and can be defined as reduced mobility due 
to dysfunction of locomotory organs, such as bones, 
muscles, joints, tendons or nerves, and its consequent 
risk of dependence for locomotion. Musculoskeletal 
pathologies that can lead to this condition including 
osteoarthritis, osteoporosis, fractures, spinal canal stenosis 
and sarcopenia [3,4]. A Japanese study carried out in 2011 
estimated that 21.5% of patients who were dependent on 
others for basic activities of daily living had locomotory 
dysfunction as the main cause of dependence [5]. In 
order to identify these patients and help diagnose LoS, a 
questionnaire called the 25-Question Geriatric Locomotive 
Function Scale (GLFS-25) was developed in 2008 [6]. The 
instrument was later translated, cross-culturally adapted and 
validated for use in the Brazilian population (GLFS-25P) [7,8]. 
Sarcopenia is another major cause of dependence for 
locomotion in older people and the syndrome assessment 
algorithm was recently updated by the European Working 
Group on Sarcopenia in Older People (EWGSOP). 
The SARC-F questionnaire is designed for initial 
screening of cases [9,10]. During its Brazilian validation, 
the questionnaire, when used in association with Calf 
Circumference (CC) measurement, proved more sensitive 
for detecting patients diagnosed with sarcopenia [11]. 
Quality of l ife reflects personal opinions and 
conceptions, based on beliefs, experiences and sensations. 
These perceptions and feelings should be evaluated 
multidimensionally, including physical, psychological 
and social domains, level of dependence, environmental 
influences and aspects of spirituality and religiosity [12]. 
The term quality of life includes, but is not limited to, 
health status and medical interventions [13], highlighting 
the relevance of a comprehensive view of the patient 
that encompasses their personal, socioeconomic, 
educational and cultural background. In order to provide 
this multidimensional approach, several quality of life 
questionnaires are used in the literature. 
The older population, especially the oldest old, often 
exhibit comorbidities that lead to functional decline. Thus, 
strategies for screening and controlling comorbidities are 
vital, starting with the recognition of possible causes of 
functional deficits and their consequent impact on quality 
of life. For this purpose, simple screening methods are 
available, such as questionnaires and tests of functioning [14]. 
Currently, knowledge about quality of life and its 
correlations with locomotion problems in the literature 
is scarce. The aim of the present study was to assess the 
influence of LoS and sarcopenia on quality of life in 
independent oldest old living in the community.
2. Materials and Methods
A cross-sectional study of the 2016 observational, 
longitudinal survey, called the LOCOMOV Project, which 
included independent older people aged 80 years or over 
living in the community in the city of São Paulo, Brazil [8] 
was conducted. This study was approved by the Research 
Ethics Committee of the Federal University of São Paulo 
(CAAE permit no. 42336720.1.0000.5505).
2.1 Sample
Individuals participating in the third wave of the 
LOCOMOV Project were assessed in the period spanning 
from February 2020 to February 2021. Exclusion criteria 
included presence of dementia syndrome, severe acute or 
decompensated chronic illness, limiting sensory deficit, 
and fracture in the last six months [15].
2.2 Data Collection
Sociodemographic data and disease history were 
collected and functioning scales applied. Participants then 
answered the GLFS-25P, SARC-F and WHOQOL-Bref 
questionnaires. Finally, physical tests were carried out to 
assess strength, gait, balance and physical performance. 
The questionnaires applied, although designed to be 
self-administered, were completed by the interviewer 
in the presence of the participant while heeding the 
recommendations to refrain from providing additional 
explanations about the questions, considering age and 
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possible visual, motor and educational limitations of 
the study participants. For comorbidity data, a personal 
history of chronic pain, nutritional status (malnutrition 
or obesity), osteoarthritis, falls in the last year and use of 
walking device were checked. Chronic pain was defined as 
pain lasting more than six months. Regarding nutritional 
status, the classification of World Health Organization 
(WHO) and Pan American Health Organization (PAHO) 
was used according to BMI, with score <23 classed as 
malnutrition and ≥ 30 as obesity [16,17]. The diagnosis of 
osteoarthritis was made by reviewing the medical record. 
Participants were probed directly about use of walking 
devices and number of falls in the last year.
2.3 Assessment Instruments
Functioning in daily life
The Katz and Lawton scales were applied, measuring 
the ability to perform basic Activities of Daily Living 
(ADLs) and Instrumental Activities of Daily Living 
(IADLs), respectively. The Katz scale is widely used 
among health professionals for the assessment of 
functional independence and the performance of six 
functions - bathing, dressing, going to the bathroom, 
transferring, continence and the ability to feed. For each 
item, the individual is considered independent if he or 
she can perform the activity without help [18]. The Lawton 
scale assesses the ability to perform instrumental activities 
such as using a telephone, doing laundry, and handling 
finances. The scale measures nine domains, each rated 
from 1 to 3 (1 denoting unable, 2 need assistance, and 3 
independent). The score ranges from 9 to 27 where the 
higher the score, the greater the person's abilities [19,20,14].
GLFS-25P
Comprising 25 questions with answers scored from 0 to 
4 points.. Total score ranges from 0 to 100 points, where 
the higher the score, the greater the locomotive limitation 
of the patient [6]. The cutoff point of ≥19 was established 
for the diagnosis of LoS in the Brazilian population, with 
86% sensitivity and 67% specificity [8].
SARC-F + CC
Five questions are asked about the ability to carry 
weight, walk unassisted, transfer from chair or bed, climb 
stairs, and number of falls in the last year. Each item is 
scored from 0 to 2, with 0 denoting no difficulty, 1 some 
difficulty and 2 failure. The scores on the 5 questions are 
added to the measure of calf circumference (CC) and, if 
this is abnormal (> 33cm for women and >34cm for men), 
the individual receives 10 more points. The total score 
ranges from 0 to 20, with values >11 indicating risk of 
sarcopenia [21].
Quality	of	life
Defined by the WHO as an individual´s "perception 
of their position in life in the context of the culture and 
value systems in which they live, and in relation to their 
goals, expectations, standards and concerns”, serves to 
help understand the influence of these limitations on 
every aspect of life. This information is essential in the 
decision-making process aimed at well-being and healthy 
aging. The WHOQOL-Bref is a tool devised by the WHO 
for assessing quality of life in adults. This is a 26-item 
reduced version of the World Health Organization Quality 
of Life Instrument 100 (WHOQOL-100), comprising 2 
general questions and 24 representing each of the 24 facets 
that make up the original instrument. The WHOQOL-
Bref is composed of the domains physical capacity 
(PHYS), psychological well-being (PSYCH), social 
relationships (SOCIAL) and the environment (ENVIR) 
of the individual. Each domain comprises questions with 
answers ranging from 1 to 5 evaluated separately [22,23].
Physical Functioning Assessment
Hand Grip (HG): Muscle strength was measured in the 
study by HG. The individual is asked to remain in a sitting 
position with shoulders adducted in neutral rotation, 
without supporting arms on any surface. The subject is 
then asked to flex the elbow at 90°, with the forearm in 
a neutral position and the wrist ranging from 0 to 30° of 
extension. Three measurements of the dominant arm, with 
an interval of one minute between them, are taken using 
the Jamar dynamometer instrument, selecting the highest 
value obtained [24]. Values <16 kg for women and <27 kg 
for men were considered impaired, according to cutoff values 
stipulated in the 2019 sarcopenia algorithm update [9].
Five Times Sit-to-Stand Test (5xSST): For this test, a 
pre-test is first performed in which the individual is asked 
to cross their arms across their chest and get up from a 
chair. If the patient is able to get up from the chair safely 
and thinks he or she is capable of performing the test, it is 
continued, whereas if the individual does not perform the 
pre-test correctly and safely, the test is ended. For older 
people aged 80 years or more, the cutoff of 14.8 seconds 
is used where those who perform the test in ≥ 14.9 
seconds have worse performance and greater impairment 
in lower limb mobility, and more susceptible to falls and 
morbidity. If the individual is not able to get up five times 
from the chair, no score is given [25,26].
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Gait Speed (GS): For this test, the individual is asked 
to walk in a straight line at their usual gait speed. The 
time the individual takes to walk 4 meters is measured, 
with total distance increased in order to allow the initial 
and final periods of deceleration/acceleration to be 
disregarded. The test is considered abnormal for GS < 0.8 
m/s [27].
Short Physical Performance Battery (SPPB): The test 
initially assesses balance in three different positions: 
patient in orthostasis, without any support point (including 
walking devices), initially with feet positioned side by 
side, later in semi-tandem and finally in tandem position. 
In each of the positions, the patient is expected to be able 
to remain still for 10 seconds. The first two positions 
score 1 if the individual manages to hold for 10 seconds 
and 0 if they do not. In the tandem position, the individual 
receives 2 points for maintaining 10 seconds, 1 point for 
managing to remain in the position for 3-9 seconds, and 0 
for <3 seconds. Gait speed is then evaluated, as described 
in the specific item. The score for this step ranges from 
0 to 4 points (0 if unable; 1 for time > 8.70 seconds; 2 
for6.21-8.69 seconds; 3 for4.82-6.20 seconds; and 4 for 
< 4.82 seconds). Finally, the 5xSST test, outlined above 
is evaluated with score ranging from 0 to 4 (0 if unable; 1 
for time > 16.70 seconds; 2 for 13.70-16.69 seconds; 3 for 
11.20-13.69 seconds; and 4 points for ≤ 11.19 seconds). 
The final score on the battery ranges from 0 to 12 and a 
cutoff point of ≤8 was established for patients with poor 
physical performance, according to the updated 2019 
sarcopenia algorithm [28,9].
2.4 Statistical Analysis
The data obtained was double keyed into the Excel 
Office 2010 program and then treated using the Statistical 
Package for Social Sciences - SPSS for Windows (SPSS 
V20) and Minitab 16. Initially, a complete descriptive 
analysis of the quantitative variables was performed, 
expressed as mean, median, quartiles (Q1, Q3), minimum, 
maximum, standard deviation, coefficient of variation 
(CV) and confidence interval (CI), representing the 
variation of the mean according to statistical probability. 
To characterize the distribution of the relative frequency 
of qualitative covariates, the Equality of Two Proportions 
Test was used. Subsequently, Pearson's Correlation 
Coefficient was used for quantitative bivariate analyses. 
The qualitative analysis of the instruments was performed 
using the chi-square test, expressed as absolute values 
and their percentages. Finally, the comparison of means 
for two or more groups was performed using Student´s 
t-test. A significance level of 0.05 (5%) was defined, with 
confidence intervals constructed with 95% statistical 
confidence.
3. Results
The init ial  sample of the LOCOMOV Project 
comprised 102 older adults with several losses thereafter. 
Regarding losses in the third wave of the study in 2020, 
there were 16 deaths, exclusion of 12 participants due to 
dementia diagnosis, 2 for decompensated chronic disease 
and 41 because of irregular follow-up (due to coronavirus 
pandemic, and others). Thus, a final sample of only 30 
participants was assessed (Figure 1).
Figure 1. Study Flowchart
Regarding the sample, most participants were female 
(80%) and widowed (80%). The mean age of participants 
was of 89.1 ± 1.5 years and mean education was 
3.48 years. For tests of functioning, most participants 
performed well, i.e. above the cutoff (Table 1). 
The percentage of participants reporting chronic pain 
(76.7%) and LoS (53.3%) was high, while the rate of 
sarcopenia (26.7%) was lower (Table 2).
LoS was statistically significantly correlated with 
quality of life according to physical (r=-0.598, p <0.001) 
and environmental (r = -0.370, p 0.044) domains, 
and exhibited a tendency towards significance for the 
psychological domain (r= - 0.335, p 0.071). Los also 
correlated positively with sarcopenia (r= 0.563, p <0.001) 
and negatively with physical performance as measured 
by the SPPB (r= -0.752, p<0.001), muscle strength ( r= 
-0.450, p 0.013) and gait speed (r= -0.707, p <0.001).
For qualitative variables, there was no statistically 
significant association between LoS and sarcopenia (p 
= 0.272). LoS showed a positive statistically significant 
association with the presence of chronic pain (93.8%; p = 
0.024) (Table 4).
Individuals diagnosed with LoS had a mean of 48.4 on 
the physical domain of quality of life compared to 69.4 
for those without LoS (p-value = 0.002) (Table 5). In 
individuals with LoS, the physical domain of quality of 
life did not differ significantly for presence or absence of 
sarcopenia (p 0.452) (Table 6).
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Table 1. Sample characteristics according to quantitative variables
Mean Median Standard Deviation CV Q1 Q3 Min Max N CI
Age 89.1 88 4.3 5% 86 92 83 101 30 1.5
Education (years) 3.48 4 3.28 94% 1 4 0 11 29 1.19
Falls (nº) 0.37 0 0.61 168% 0 1 0 2 30 0.22
Physical Tests
HG 21.9 22 7.1 32% 19 24 2 38 30 2.5
GS 0.73 0.75 0.29 40% 0.49 0.96 0.02 1.33 30 0.10
5xSST 12.5 11 5.1 41% 9 13 8 31 25 2.0
SPPB 8.40 9 3.29 39% 6 12 1 12 30 1.18
LoS GLFS-25P 23.3 20 18.6 80% 10 33 2 81 30 6.6
Sarcopenia SARC-F + CC 6.20 5 5.59 90% 1 11 0 17 30 2.00
WHOQOL- Bref
PHYS 58.2 61 19.6 34% 54 71 14 100 30 7.0
PSYCH 67.2 67 16.0 24% 55 79 29 88 30 5.7
SOCIAL 79.9 83 15.9 20% 75 92 33 100 30 5.7
ENVIR 70.2 72 15.6 22% 63 80 22 94 30 5.6
Table 2. Sample characteristics according to qualitative variables




















Married 4 13.3% <0.001
Divorced 1 3.3% <0.001
Single 1 3.3% <0.001









Part. Dependence 2 6.7%
IADL
Independence 11 36.7% Ref.
Mild dependence 10 33.3% 0.787
Moderate dependence 6 20.0% 0.152
Severe dependence 2 6.7% 0.005
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Corr (r) -0.275            
P-value 0.141            
Falls
Corr (r) 0.330 -0.195           
P-value 0.075 0.301           
HG
Corr (r) -0.154 0.092 -0.112          
P-value 0.417 0.630 0.554          
GS
Corr (r) -0.424 0.047 0.039 0.291         
P-value 0.020 0.806 0.836 0.119         
5xSST
Corr (r) 0.309 -0.051 -0.165 -0.108 -0.433        
P-value 0.133 0.809 0.431 0.607 0.031        
SPPB
Corr (r) -0.420 0.049 0.078 0.348 0.857 -0.645       
P-value 0.021 0.797 0.680 0.059 <0.001 0.001       
GLFS-25P
Corr (r) 0.236 0.001 0.091 -0.450 -0.707 0.052 -0.752      
P-value 0.210 0.995 0.633 0.013 <0.001 0.807 <0.001      
SARC-F + CC
Corr (r) 0.199 0.117 0.179 -0.466 -0.327 -0.164 -0.446 0.563     
P-value 0.291 0.537 0.345 0.009 0.078 0.435 0.014 0.001     
PHYS
Corr (r) 0.021 -0.259 0.117 0.081 0.369 -0.050 0.325 -0.598 -0.205    
P-value 0.913 0.167 0.537 0.672 0.045 0.814 0.080 <0.001 0.278    
PSYCH
Corr (r) 0.123 -0.415 -0.167 0.092 0.160 0.129 0.261 -0.335 -0.405 0.376   
P-value 0.516 0.023 0.377 0.629 0.398 0.537 0.164 0.071 0.026 0.040   
SOCIAL
Corr (r) 0.327 -0.370 0.061 -0.299 -0.038 -0.030 -0.011 -0.031 -0.087 0.320 0.701  
P-value 0.077 0.044 0.749 0.109 0.843 0.889 0.953 0.872 0.648 0.085 <0.001  
ENVIR
Corr (r) 0.208 -0.473 -0.091 0.168 0.120 0.052 0.218 -0.370 -0.408 0.497 0.842 0.674
P-value 0.271 0.008 0.633 0.374 0.529 0.805 0.248 0.044 0.025 0.005 <0.001 <0.001
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Table 4. Association between LoS and others covariates
Normal Impaired Total
P-value
N % N % N %
ADLs
Independence 14 87.5% 14 100% 28 93.3%
0.276
Part. Dependence 2 12.5% 0 0.0% 2 6.7%
IADLs
Independence 3 18.8% 8 57.1% 11 36.7%
0.149
Mild dependence 7 43.8% 3 21.4% 10 33.3%
Moderate dependence 3 18.8% 3 21.4% 6 20.0%
Severe dependence 2 12.5% 0 0.0% 2 6.7%
Total dependence 1 6.3% 0 0.0% 1 3.3%
Civil Status
Married 2 12.5% 2 14.3% 4 13.3%
0.564
Divorced 0 0.0% 1 7.1% 1 3.3%
Single 1 6.3% 0 0.0% 1 3.3%
Widowed 13 81.3% 11 78.6% 24 80.0%
Gender
Female 14 87.5% 10 71.4% 24 80.0%
0.202
Male 2 12.5% 4 28.6% 6 20.0%
Malnutrition
No 15 93.8% 11 78.6% 26 86.7%
0.213
Yes 1 6.3% 3 21.4% 4 13.3%
Walking device
No 7 43.8% 10 71.4% 17 56.7%
0.096
Yes 9 56.3% 4 28.6% 13 43.3%
Chronic pain
No 1 6.3% 6 42.9% 7 23.3%
0.024
Yes 15 93.8% 8 57.1% 23 76.7%
Obesity
No 12 75.0% 13 92.9% 25 83.3%
0.179
Yes 4 25.0% 1 7.1% 5 16.7%
Osteoarthritis
No 3 18.8% 3 21.4% 6 20.0%
0.343
Yes 13 81.3% 11 78.6% 24 80.0%
HG
Normal 13 81.3% 10 71.4% 23 76.7%
0.275
Impaired 3 18.8% 4 28.6% 7 23.3%
5xSST
< 14.8seg 8 72.7% 12 85.7% 20 80.0%
0.283
≥14.8seg 3 27.3% 2 14.3% 5 20.0%
SPPB
Inappropriate 9 56.3% 4 28.6% 13 43.3%
0.096
Appropriate 7 43.8% 10 71.4% 17 56.7%
GS
<0.8m/s 11 68.8% 6 42.9% 17 56.7%
0.110
≥0.8m/s 5 31.3% 8 57.1% 13 43.3%
24
Journal of Geriatric Medicine | Volume 03 | Issue 02 | October 2021
4. Discussion
In the present study, mean age was 89.1 years in the 
clinically compensated individuals with no cognitive 
impairments impacting functioning. In the oldest old 
assessed, many variables had high coefficients of 
variation, such as education, number of falls in the last 
year, and LoS and sarcopenia screening questionnaires, 
revealing heterogeneity among the participants.
Regarding LoS,  53.3% of  the sample had an 
established diagnosis according to the GLFS-25P. A 
statistically significant relationship between LoS and 
chronic pain was found. This data is essential to draw 
attention to a diagnosis that is often neglected in health 
care. Appropriate treatment of chronic pain can improve 
performance and intrinsic capacity of older individuals.
The study results confirmed a correlation between LoS 
and worse performance on the short physical performance 
battery (SPPB) and in gait speed (GS), an expected 
finding, given the impact of LoS on patient functioning 
and independence for locomotion, as previously described 
in the literature [5].
There are few studies investigating the impact of this 
syndrome on the perception of quality of life. In the 
second wave of the Locomov project, conducted by Arbex 
et al. in 2020, LoS was correlated with worse scores in 
physical, psychological and environmental domains of 
quality of life on the WHOQOL-Bref [8]. Although the 
present study was based on the initial sample of the second 
wave, there was a regular correlation between LoS and 
the physical domain only. However, this difference might 
be explained by the reduced current sample population, 
in that the patients who remained in the project were 
probably those with better physical performance and less 
locomotive limitations in the previous study.
The association between LoS and worse quality of life 
scores implies that physical limitation has a deleterious effect 
on the quality of aging of the oldest old studied. Preserved 
ability to move around, climb stairs and carry weight, i.e., 
maintain some locomotive independence, is associated with 
better perceived quality of life by older adults [8].
Sarcopenia was present in only 26.7% of the sample 
and was not associated with LoS. This lack of association 
may have occurred due to the low prevalence of 
sarcopenia and small sample size. LoS was associated 
with worse quality of life regardless of the presence of 
sarcopenia.
Promoting musculoskeletal health during aging is 
believed to be beneficial by ensuring longer functional 
independence, control of comorbidities that impact 
locomotion such as chronic pain, and consequently better 
intrinsic capacity of the individual and enhanced quality 
of life.
Table 5. Association between LoS and quality of life
WHOQOL-Bref LoS Mean Median Standard Deviation CV Min Max N CI P-value
PHYS
Yes 48.4 53.6 19.0 39% 14.3 75.0 16 9.3
0.002
No 69.4 67.9 13.8 20% 53.6 100.0 14 7.2
PSYCH
Yes 64.1 62.5 17.3 27% 29.2 87.5 16 8.5
0.254
No 70.8 79.2 14.2 20% 45.8 87.5 14 7.4
SOCIAL
Yes 77.9 79.2 14.0 18% 41.7 100.0 16 6.9
0.472
No 82.1 87.5 18.2 22% 33.3 100.0 14 9.5
ENVIR
Yes 67.2 67.2 17.0 25% 21.9 93.8 16 8.3
0.264
No 73.7 78.1 13.6 19% 46.9 90.6 14 7.1
Table 6. Association between LoS, in presence or absence of sarcopenia, and physical domain of quality of life
WHOQOL-Bref Sarcopenia Mean Median
Standard 
Deviation
CV Min Max N CI P-value
PHYS
Yes 42.9 39.3 26.4 62% 14.3 75.0 5 23.1
0.452
No 50.9 53.6 15.4 30% 25.0 75.0 11 9.1
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Study limitations 
The high rate of death and other outcomes, such 
as dementia syndrome, observed in the longitudinal 
LOCOMOV Project  led to a small  sample size. 
Another factor further limiting the sample size was the 
COVID-19 pandemic. The older population is a risk 
group for the virus and, from the outset of the pandemic, 
recommendations emphasize that this group avoids 
unnecessary exposure and remain in contact only with 
family members they live with. Thus, many patients failed 
to attend routine geriatric appointments, largely justifying 
the follow-up losses observed in the study, since data 
collection was concomitant with outpatient consultations 
and started a month prior to the pandemic restrictions in 
Brazil. 
5. Conclusions
Despite the small sample, the present study suggested 
a statistically significant association between LoS and 
chronic pain and also worse performance by participants 
with LoS on test of functioning such as gait speed and 
physical performance. LoS was associated with worse 
health-related quality of life regardless of the presence of 
sarcopenia. Recognizing the characteristics of the oldest 
old in relation to their musculoskeletal limitations is 
important to guide effective prevention and rehabilitation 
actions for functional dependence, contributing to the 
quality of life and healthy aging of this population.
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